Health groups raise important substantive and procedural issues with PM’s application to make reduced exposure claims for IQOS 3

The American Academy of Pediatrics, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids, and Truth Initiative have submitted a well-conceived public comment to FDA opposing Philip Morris’ request to make “modified exposure” claims about the new IQOS 3. In addition to providing important information about new studiesContinue reading “Health groups raise important substantive and procedural issues with PM’s application to make reduced exposure claims for IQOS 3”

Industry easily adapts to FDA’s limited action on e-cig flavors

In response to skyrocketing youth e-cigarette use, driven largely by Juul removable pod flavored e-cigs, in January 2020, FDA said they would “prioritize enforcement” against most flavored pod e-cigs. Not surprisingly, youth and young adults have shifted to menthol and disposable flavored e-cigs that FDA is not prioritizing. Now Shivani Gaiha and her colleagues atContinue reading “Industry easily adapts to FDA’s limited action on e-cig flavors”

Philip Morris’ modified risk tobacco product application for IQOS 3 does not adequately consider new research on IQOS’s appeal to adolescents or young adults, consumer perceptions, or the likelihood that the consumers will misunderstand labeling and marketing; FDA should not issue a reduced exposure MRTP order

Philip Morris has applied for permission from FDA to make reduced exposure claims for its new IQOS 3 heated tobacco product. My colleagues and I at the UCSF TCORS have submitted a public comment opposing this request. The main thrust of the comment is a discussion of 57 papers published since 2018 that consider IQOS’sContinue reading “Philip Morris’ modified risk tobacco product application for IQOS 3 does not adequately consider new research on IQOS’s appeal to adolescents or young adults, consumer perceptions, or the likelihood that the consumers will misunderstand labeling and marketing; FDA should not issue a reduced exposure MRTP order”

Philip Morris ordered to suspend IQOS sales in the US

After losing a patent dispute with British American Tobacco over its IQOS heated tobacco product, Philip Morris has been forced to suspend sales of the device in the US. Specifically, BAT says that the heating element in IQOS violates a BAT patent. Philip Morris had met with the FDA and urged it to intervene withContinue reading “Philip Morris ordered to suspend IQOS sales in the US”

PM’s modified risk tobacco product application for IQOS 3 ignores new published research on toxic emissions in IQOS aerosol and does not demonstrate benefits to individual or population health; FDA should deny its application to make reduced exposure claims

My UCSF TCORS colleagues and I submitted this public comment to the FDA opposing Philip Morris’ application for authorization for them to make modified risk claims for its new IQOS 3 heated tobacco product. A PDF of the comment is here. The Regulations.gov tracking number is kur-iypq-uf1v. Here is the comment: The supplemental modified riskContinue reading “PM’s modified risk tobacco product application for IQOS 3 ignores new published research on toxic emissions in IQOS aerosol and does not demonstrate benefits to individual or population health; FDA should deny its application to make reduced exposure claims”

How Big Tobacco worked behind the scenes in Louisiana for “tort reform”

Tanner Wakefield and I just published “The Tobacco Industry’s Tort Reform Campaign to Avoid Liability in Louisiana” in Addictive Behaviors. This paper uses previously secret internal tobacco industry documents to describe how the tobacco companies worked through intermediaries to promote “tort reform” that would shield it from legal liability for all the death and destructionContinue reading “How Big Tobacco worked behind the scenes in Louisiana for “tort reform””

“Big Vape” is well worth reading

As I said in my review of Lauren Etter’s history of Juul, The Devil’s Playbook, my definition of a good book on tobacco is that I learn things I didn’t already know from reading it. Even after reading Etter’s book, Jamie Ducharme’s Big Vape is a good book. While all the key major events appearContinue reading ““Big Vape” is well worth reading”

“Move Fast and Vape Things” is worth watching

The New York Times just released its new one hour documentary on the origins of Juul, Move Fast and Vape Things. (You can watch a trailer and some clips from the film and link to Hulu, where the full film is available, here.) The film includes interviews with an addicted teen, the two men whoContinue reading ““Move Fast and Vape Things” is worth watching”

British American Tobacco (BAT) Conducted Extensive and Potentially Illegal Activity To Undermine Health Policy, Sabotage Competitors And Secure Profits In Africa

Researchers led by Anna Gilmore at the University of Bath just published three jaw-dropping reports on British American Tobacco’s (BAT) allegedly illegal activities in Africa to undermine competitors through surveillance, bribes and dirty tricks. (They also contributed 273 new documents to the UCSF Truth Tobacco Industry Documents Library they used in this work, so theContinue reading “British American Tobacco (BAT) Conducted Extensive and Potentially Illegal Activity To Undermine Health Policy, Sabotage Competitors And Secure Profits In Africa”

Tobacco documents: The end of the beginning

When I got the first box of around 4000 pages of secret tobacco industry documents on May 12, 1994, I thought they would have an impact, but didn’t have a clue as to how big that impact would be. Being able to look inside the tobacco companies to appreciate — in their own words —Continue reading “Tobacco documents: The end of the beginning”